Therefore, we propose overexpression of AKAP1 and modulation of Drp1 phosphorylation at Ser637 as therapeutic strategies for neuroprotective intervention in glaucoma and other mitochondria-related optic neuropathies. Here, DNM1L is linked to glaucoma.